SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Dipexium Pharma - DPRX

NEW YORK, Jan. 25, 2017 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating Dipexium Pharmaceuticals, Inc. ("Dipexium" or the "Company")(NASDAQ: DPRX) and its Board of Directors for potential federal law violations and/or breaches of fiduciary duties in connection the acquisition of PLx Pharma Inc. (the "Merger").

Click here for more information: www.monteverdelaw.com/investigations.  It is free and there is no cost or obligation to you.

The investigation focuses on whether Dipexium and/or its Board of Directors violated federal securities laws and/or breached their fiduciary duties to the Company's stockholders by 1) failing to properly value the Merger and 2) failing to disclose all material information in connection with the Merger.

Monteverde & Associates PC is a boutique class action securities and consumer litigation law firm committed to protecting shareholders and consumers from corporate wrongdoing.  Monteverde & Associates PC lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct.

If you own common stock in Dipexium and wish to obtain additional information and protect your investments free of charge, please visit us at www.monteverdelaw.com/investigations or Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. 59^th Floor
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2017 Monteverde & Associates PC.  The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter. 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-monteverde--associates-pc-announces-an-investigation-of-dipexium-pharma---dprx-300396992.html

SOURCE Monteverde & Associates PC